Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
CACIDoximity

CACI vs Doximity

This page compares CACI and Doximity across business models, financial performance, and market context, offering clear, neutral insights for readers. It outlines different approaches, growth considera...

Investment Analysis

CACI

CACI

CACI

Pros

  • CACI International delivered strong revenue growth of 12.64% in 2025, reaching $8.63 billion, demonstrating solid top-line expansion.
  • Analyst consensus rates CACI as a 'Strong Buy' with price targets indicating potential upside of around 9% to over 13% within the next year.
  • The company maintains a diversified portfolio offering advanced cyber, intelligence, and IT solutions, supporting national security and government transformation.

Considerations

  • Despite revenue growth, CACI's net profit margin remains modest at around 5.7%, indicating potential pressure on profitability.
  • CACI carries a moderate debt-to-equity ratio of approximately 69%, which could pose leverage risks in volatile markets.
  • The stock's valuation, with a current P/E ratio near 22–26, might limit upside compared to risk, with some forecasts suggesting price volatility.
Doximity

Pros

  • Doximity has rapidly grown as a leading digital platform connecting healthcare professionals, capitalising on telehealth and digital transformation trends.
  • Recent financial updates indicate expanding user engagement and revenue growth supported by strong demand in healthcare communications.
  • The company benefits from a niche, defensible market position with network effects and scalable software solutions tailored to medical professionals.

Considerations

  • Doximity faces regulatory uncertainties and evolving privacy standards in the healthcare sector, which could impact operations and growth.
  • The stock is subject to market volatility driven by healthcare sector economic cycles and sensitivity to changes in digital ad spending.
  • Competitive pressures from bigger tech companies expanding into digital health and professional networking could challenge Doximity's market share.

Which Baskets Do They Appear In?

The Pentagon's Software Pivot

The Pentagon's Software Pivot

The U.S. Army's $10 billion enterprise agreement with Palantir signals a major shift in defense procurement toward consolidated software contracts. This new model creates opportunities for other large technology firms capable of providing streamlined, large-scale IT and AI solutions to the military.

Published: August 4, 2025

Explore Basket
Palantir's AI Ascent

Palantir's AI Ascent

This carefully curated group of stocks represents the backbone of today's AI revolution. Selected by professional analysts, these companies provide the essential hardware, infrastructure, and software that power AI growth across government and commercial sectors.

Published: July 14, 2025

Explore Basket
AI & Big Data for Government

AI & Big Data for Government

These carefully selected companies are leading the digital transformation within federal agencies. Analysts are watching this space closely as government spending on AI and data technology continues to grow, potentially creating long-term investment opportunities.

Published: July 1, 2025

Explore Basket
Big Brother Basket

Big Brother Basket

This carefully curated collection of stocks gives you access to companies building the future of surveillance and security technology. Our expert analysts have selected leaders in digital monitoring, data intelligence, and cybersecurity poised to benefit from growing government and corporate spending.

Published: June 17, 2025

Explore Basket

Buy CACI or DOCS in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

CACIManhattan Associates

CACI vs Manhattan Associates

CACI vs Manhattan Associates

CACIDuolingo

CACI vs Duolingo

CACI vs Duolingo: A stock comparison

CACIProcore

CACI vs Procore

CACI vs Procore

Frequently asked questions